HOLLY GUSTAFSON: Open Payments
NPI 1396173886 · FORT COLLINS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 25 payments from 12 companies in 2025. Trend: 2023 $612 · 2024 $825 · 2025 $514
Food & beverage: $514
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $86 |
| ABBVIE INC. | 3 | $85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $66 |
| Exact Sciences Corporation | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Cranial Technologies, Inc | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $34 |
| Amgen Inc. | 2 | $31 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
| Seqirus USA Inc | 1 | $27 |
Products named: JARDIANCE, MOUNJARO, Cologuard Collection Kit, XIFAXAN, Doc Band, QULIPTA, CAPLYTA, VRAYLAR.
Industry payments across CO — which companies pay providers there.
